Search

Search Constraints

You searched for: Author/Creator Heise, Tim

Search Results

1. A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Issue 5 (31st January 2023)

3. ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Issue 4 (18th January 2021)

4. Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project. (March 2019)

5. Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes. Issue 7 (8th April 2019)

6. BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study. Issue 4 (17th January 2019)